Email updates

Keep up to date with the latest news and content from BMC Developmental Biology and BioMed Central.

Open Access Highly Accessed Research article

Foxl2 functions in sex determination and histogenesis throughout mouse ovary development

José Elias Garcia-Ortiz12, Emanuele Pelosi1, Shakib Omari1, Timur Nedorezov1, Yulan Piao1, Jesse Karmazin1, Manuela Uda3, Antonio Cao3, Steve W Cole4, Antonino Forabosco5, David Schlessinger1* and Chris Ottolenghi16*

Author Affiliations

1 Laboratory of Genetics, NIA/NIH-IRP, Baltimore, USA

2 División de Genética, Centro de Investigación Biomédica de Occidente, CMNO-IMSS, Guadalajara, México

3 Istituto di Neurogenetica e Neurofarmacologia, Consiglio Nazionale delle Ricerche, Cittadella Universitaria di Monserrato, Monserrato, Cagliari, Italy

4 Department of Medicine, Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA 90095-1678, USA

5 Unità di Genetica Medica, Università di Modena, Modena, Italy

6 Current address: UMR-S747 Inserm-Université Paris Descartes, Paris, France

For all author emails, please log on.

BMC Developmental Biology 2009, 9:36  doi:10.1186/1471-213X-9-36

Published: 18 June 2009

Abstract

Background

Partial loss of function of the transcription factor FOXL2 leads to premature ovarian failure in women. In animal models, Foxl2 is required for maintenance, and possibly induction, of female sex determination independently of other critical genes, e.g., Rspo1. Here we report expression profiling of mouse ovaries that lack Foxl2 alone or in combination with Wnt4 or Kit/c-Kit.

Results

Following Foxl2 loss, early testis genes (including Inhbb, Dhh, and Sox9) and several novel ovarian genes were consistently dysregulated during embryonic development. In the absence of Foxl2, expression changes affecting a large fraction of pathways were opposite those observed in Wnt4-null ovaries, reinforcing the notion that these genes have complementary actions in ovary development. Loss of one copy of Foxl2 revealed strong gene dosage sensitivity, with molecular anomalies that were milder but resembled ovaries lacking both Foxl2 alleles. Furthermore, a Foxl2 transgene disrupted embryonic testis differentiation and increased the levels of key female markers.

Conclusion

The results, including a comprehensive principal component analysis, 1) support the proposal of dose-dependent Foxl2 function and anti-testis action throughout ovary differentiation; and 2) identify candidate genes for roles in sex determination independent of FOXL2 (e.g., the transcription factors IRX3 and ZBTB7C) and in the generation of the ovarian reserve downstream of FOXL2 (e.g., the cadherin-domain protein CLSTN2 and the sphingomyelin synthase SGMS2). The gene inventory is a first step toward the identification of the full range of pathways with partly autonomous roles in ovary development, and thus provides a framework to analyze the genetic bases of female fertility.